tiprankstipranks

John Kollins Insider Profile

4 Followers
John Kollins, CEO, Director at Mateon Therapeutics, holds 0.00 shares in Mateon Therapeutics (Ticker: MATN), holds ― shares in Satsuma Pharmaceuticals (Ticker: STSA), holds 4.16K shares in Paratek Pharmaceuticals (Ticker: PRTK). Most recently, John Kollins ― shares of Mateon Therapeutics on ― for an estimated value of ―.
tipranks
John Kollins

John Kollins
Mateon Therapeutics (MATN)
CEO, Director

Not Ranked
John Kollins has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$26K
100.00%
0.00%
0.00%
A breakdown of John Kollins's holdings

Insider Roles

Paratek Pharmaceuticals
(PRTK)
SVP, Chief Business Officer
Mateon Therapeutics
(MATN)
CEO, Director
Satsuma Pharmaceuticals
(STSA)
President and CEO, Director
Roles that John Kollins holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by John Kollins

John Kollins's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Mateon Therapeutics
CEO, Director
$0.00
Satsuma Pharmaceuticals
President and CEO, Director
Paratek Pharmaceuticals
Oct 30, 2014
SVP, Chief Business Officer
Uninformative Buy
89.79K
$25.80K
List of latest transactions for each holding click on a transaction to see John Kollins's performance on stock

John Kollins insider profile FAQ

What is the percentage of profitable transactions made by John Kollins?
The percentage of profitable transactions made by John Kollins is ―.
    What is the average return per transaction made by John Kollins?
    The average return per transaction made by John Kollins is ―.
      What stocks does John Kollins hold?
      John Kollins holds: MATN, STSA, PRTK stocks.
        What was John Kollins’s latest transaction?
        John Kollins latest transaction was an Uninformative Buy of ―.
          What was John Kollins's most profitable transaction?
          John Kollins’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is John Kollins's role in Mateon Therapeutics?
            John Kollins's role in Mateon Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.